[1] Biggs P M,Payne L N.Studies on Marek's disease.Ⅰ.Experimental transmission[J].Journal of the National Cancer Institute,1967,39(2):267-280. [2] 邓博文,梁 伟,刘明春,等.马立克氏病的研究进展及防制策略[J].中国畜牧兽医,2006,33(12):66-69. [3] Payne L N.Marek's disease virus (Herpesviridae)[J].Encyclopedia Virol,1999,2:945-946. [4] Witter R L.Increased virulence of Marek's disease virus field isolates[J].Avian Dis,1997,41(1):149-163. [5] Churchill A E,Payne L N,Chubb R C.Immunization against Marek's disease using a live attenuated virus[J].Nature,1969,221(5182):744-747. [6] Okazaki W,Purchase H G,Burmester B R.Protection against Marek's disease by vaccination with a herpesvirus of turkeys[J].Avian Dis,1970,14(2):413-429. [7] Witter R L,Nazerian K,Purchase H G,et al.Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus[J].Am J Vet Res,1970,31(3):525-538. [8] Witter R L,Silva R F,Lee L F.New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses:Selected biological and molecular characteristics[J].Avian Dis,1987,31(4):829-840. [9] Witter R L.Safety and comparative efficacy of the CVI988/Rispens vaccine strain[A].Proceedings of the 4th international symposium on Marek's disease,19th World Poultry Congress[C].1992. [10] Rispens B H,van Vloten H,Mastenbroek N,et al.Control of Marek's disease in the Netherlands.Ⅱ.Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus[J].Avian Dis,1972,16(1):126-138. [11] Rispens B H,van Vloten H,Mastenbroek N,et al.Control of Marek's disease in the Netherlands.Ⅰ.Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials[J].Avian Dis,1972,16(1):108-125. [12] 瞿 浩,舒鼎铭,杨纯芬,等.鸡抗马立克氏病育种的挑战和机遇[J].中国畜牧兽医,2004,31(11):27-30. [13] Reddy S M,Lupiani B,Gimeno I M,et al.Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs:Use of a pp38 mutant to validate the technology for the study of gene function[J].Pro Natl Acad Sci USA,2002,99(10):7054-7059. [14] Cui H Y,Wang Y F,Shi X M,et al.Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens[J].J Virological Methods,2009,156(1-2):66-72. [15] Sun A J,Xu X Y,Petherbridge L,et al.Functional evaluation of the role of reticuloendotheliosis virus long terminal repeat (LTR) integrated into the genome of a field strain of Marek's disease virus[J].Virology,2010,397(2):270-276. [16] Lee L F,Lupiani B,Silva R F,et al.Recombinant Marek's disease virus (MDV) lacking the meq oncogene confers protection against challenge with a very virulent plus strain of MDV[J].Vaccine,2008,26(15):1887-1892. [17] Lee L F,Heidari M,Zhang H,et al.Cell culture attenuation eliminates rMd5Δmeq-induced bursal and thymic atrophy and renders the mutant virus as an effective and safe vaccine against Marek's disease[J].Vaccine,2012,30(34):5151-5158. [18] Lee L F,Kreager K S,Arango J,et al.Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking meq oncogene in commercial chickens[J].Vaccine,2010,28(5):1294-1299. [19] 张 志,崔治中.整合进禽反转录病毒基因组片段的鸡马立克氏病病毒重组野毒株的发现[J].中国科学,2004,34(4):317-324. [20] Su S,Cui N,Cui Z,et al.Complete genome sequence of a recombinant Marek's disease virus field strain with one reticuloendotheliosis virus long terminal repeat insert[J].J Virol,2012,86(24):13818-13819. [21] 苏 帅,李延鹏,孙爱军,等.敲除meq的鸡马立克氏病毒强毒株对超强毒的免疫保护作用[J].微生物学报,2010,50(3):380-386. [22] Li Y,Sun A,Su S,et al.Deletion of the meq gene significantly decreases immunosuppression in chickens caused by pathogenic Marek's disease virus[J].Virol J,2011,8:2. [23] 苏 帅.重组马立克氏病毒及其突变株生物学活性的比较研究[D].泰安:山东农业大学,2013. [24] Petherbridge L,Brown A C,Baigent S J,et al.Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes[J].J Virol,2004,78(23):13376-13380. [25] Zhao Y,Petherbridge L,Smith L P,et al.Self-excision of the BAC sequences from the recombinant Marek's disease virus genome increases replication and pathogenicity[J].Virol J,2008,5:19. [26] Petherbridge L,Howes K,Baigent S J,et al.Replication-competent bacterial artificial chromosomes of Marek's disease virus:Novel tools for generation of molecularly defined herpesvirus vaccines[J].J Virol,2003,77(16):8712-8718. [27] Baigent S J,Petherbridge L J,Smith L P,et al.Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease[J].J Gen Virol,2006,87(4):769-776. [28] Silva R F,Dunn J R,Cheng H H,et al.A meq-deleted Marek's disease virus cloned as a bacterial artificial chromosome is a highly efficacious vaccine[J].Avian Dis,2010,54(2):862-869. [29] Reddy S M,Sun A,Khan O A,et al.Cloning of a very virulent plus,686 strain of Marek's disease virus as a bacterial artificial chromosome[J].Avian Dis,2013,57(2):469-473. [30] Jarosinski K W,Osterrieder N.Further analysis of Marek's disease virus horizontal transmission confirms that U(L)44 (gC) and U(L)13 protein kinase activity are essential,while U(S)2 is nonessential[J].J Virol,2010,84(15):7911-7916. [31] Jarosinski K W,Margulis N G,Kamil J P,et al.Horizontal transmission of Marek's disease virus requires US2,the UL13 protein kinase,and gC[J].J Virol,2007,81(19):10575-10587. [32] 孙爱军,Petherbridge L,Zhao Y G,等.带有REV-LTR 片段的MDV 野毒株GX0101 BAC 克隆的构建及拯救病毒的致病性分析[J].科学通报,2009,54(11):1541-46. [33] Niikura M,Kim T,Silva R F,et al.Virulent Marek's disease virus generated from infectious bacterial artificial chromosome clones with complete DNA sequence and the implication of viral genetic homogeneity in pathogenesis[J].J Gen Virol,2011,92(3):598-607. |